Latest News about PRTA
Recent news which mentions PRTA
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
March 16, 2022
Tickers
PRTA
From Benzinga
The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings
February 18, 2022
From Benzinga
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
February 17, 2022
From Benzinga
Earnings Scheduled For February 17, 2022
February 17, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
February 13, 2022
From Benzinga
Why Jim Cramer Prefers This Mining Stock Over Vale
January 13, 2022
From Benzinga
The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact
January 13, 2022
From Benzinga
4 Stocks Insiders Are Buying
January 13, 2022
From Benzinga
50 Biggest Movers From Yesterday
January 13, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 12, 2022
From Benzinga
28 Stocks Moving In Wednesday's Mid-Day Session
January 12, 2022
From Benzinga
Mid-Morning Market Update: Markets Open Higher; US Inflation Rate Rises To 7% In December
January 12, 2022
From Benzinga
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
December 07, 2021
From InvestorPlace
7 A-Rated Biotechs to Buy for the Long Run
December 03, 2021
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
From Benzinga
7 A-Rated Healthcare Stocks to Buy for the Long Haul
November 01, 2021
Tags
PFE
NASDAQ:BNTX,NASDAQ:JYNT,NASDAQ:BRKR,NASDAQ:HSKA,NASDAQ:PRTA,NASDAQ:INMD,NASDAQ:ALKS,NYSE:PFE
PRTA
From InvestorPlace
What 8 Analyst Ratings Have To Say About Prothena Corp
September 20, 2021
Tickers
PRTA
From Benzinga
With Prothena Up Over 500% This Year, Is It Too Late to Get in?
September 18, 2021
From Motley Fool
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
